Analyzing Vivani Medical (NASDAQ:VANI) and Gadsden Properties (OTCMKTS:GADS)

Gadsden Properties (OTCMKTS:GADS) and Vivani Medical (NASDAQ:VANI) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends.

Analyst Ratings

This is a summary of current recommendations and price targets for Gadsden Properties and Vivani Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gadsden Properties	0	0	0	0	0.00
Vivani Medical	0	0	1	0	3.00

Vivani Medical has a consensus target price of $3.00, indicating a potential upside of 165.49%. Given Vivani Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Vivani Medical is more favorable than Gadsden Properties.

Institutional & Insider Ownership

6.8% of Vivani Medical shares are owned by institutional investors. 5.0% of Gadsden Properties shares are owned by insiders. Comparatively, 44.3% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Gadsden Properties and Vivani Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Gadsden Properties	N/A	N/A	N/A
Vivani Medical	N/A	-102.42%	-49.21%

Earnings and Valuation

This table compares Gadsden Properties and Vivani Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gadsden Properties	N/A	N/A	N/A	N/A	N/A
Vivani Medical	N/A	N/A	-$25.65 million	($0.45)	-2.51

Volatility and Risk

Gadsden Properties has a beta of -5.57, suggesting that its share price is 657% less volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 3.22, suggesting that its share price is 222% more volatile than the S&P 500.

Summary

Vivani Medical beats Gadsden Properties on 6 of the 8 factors compared between the two stocks.

About Gadsden Properties

Gadsden Properties, Inc. is a Nevada corporation that was formed on December 28, 2010. Gadsden concentrates primarily on investments in high quality income-producing assets, residential developments and other opportunistic commercial properties in secondary and tertiary markets across the United States. The Company derives value from smaller, flexible retail investments that range from $5 million to $50 million and off-market mixed-use properties ranging from $50 million to $250 million. As a result of this chosen strategy, we believe that Gadsden is developing a unique competitive advantage that generally allows the Company to invest in markets and assets that are often overlooked by larger institutional investors, such as publicly-traded REITs and other large institutional investors. As part of its strategy, Gadsden attracts specific sellers that prefer the tax deferral advantages offered through issuing operating partnership units in exchange for their properties. These real estate assets are typically operated by independent owners that are seeking to monetize their real estate holdings, and who are typically not well capitalized or well-seasoned real estate operators. These transactions create a variety of outcomes for Gadsden and the sellers typically resulting in lease-up and value-added opportunities that may not be otherwise achieved.

About Vivani Medical

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.